Health
State of Health Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19
Just Earth News | @justearthnews | 14 Jan 2021, 09:56 pm Print
China COVID-19 Vaccine Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval, reports BBC.
The vaccine is one of the two which the Brazilian government has lined up.
Brazil is one of the worst-hit COVID-19 nations in the world.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response, reports BBC.
More Health
- New study shows vaccine campaigns cut deaths by nearly 60 per cent
- New study reveals relationship between caffeine consumption and slow cellular ageing
- Every hour, 100 people die of loneliness-related causes, says WHO
- DR Congo: New initiative to eliminate HIV in children ‘a beacon of hope’, says UN
- WHO study shows tobacco control efforts protect three-quarters of the world’s population
